SCHEMBL26550286

SCHEMBL26550286

CC(C)Nc1cc(OCCCO)ccn1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.40
ADRB2 P07550 1/20 0.39
FDPS P14324 2/20 0.38
MAPK14 Q16539 5/20 0.38
ADRA1D P25100 1/20 0.37
HTR2C P28335 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
PDE2A O00408 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
P2RY12 Q9H244 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK10 P53779 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
KDM4D Q6B0I6 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RIOK2 Q9BVS4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26550285 0.92 MAPK14 (0.41) HTR7ADRB2FDPSMAPK14ADRA1D
SCHEMBL26548755 0.82 KDM4E (0.44) HTR7ALDH1A1SMN1; SMN2
SCHEMBL26548744 0.81 NOS1 (0.44) HTR7FDPSMAPK14MAPK10HRH4
SCHEMBL26550287 0.81 CHRNB2 (0.44) HTR7ALDH1A1
SCHEMBL19728670 0.80 RIOK2 (0.48) ALDH1A1MAPK10RIOK2
SCHEMBL19736190 0.78 ALDH1A1 (0.46) MAPK14ALDH1A1RIOK2
SCHEMBL26548519 0.77 CCR1 (0.52) FDPSMAPK14MAPK10HRH4RIOK2
SCHEMBL26547682 0.76 CYP2C9 (0.43) HTR7MAPK14ALDH1A1MAPK10HRH4
SCHEMBL26550280 0.76 FDPS (0.48) HTR7FDPSMAPK14ALDH1A1MAPK10
SCHEMBL19728667 0.72 RIOK2 (0.49) ALDH1A1MAPK10RIOK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196975-A1 COMPOUNDS THAT INTERACT WITH RAS SUPERFAMILY PROTEINS FOR TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2023-10-12 WO disclosed